newsfilter
← Latest News
Business Wire·

Better Therapeutics to Host Conference Call to Review Results from Pivotal Clinical Trial of BT-001 for Type 2 Diabetes

Conference call and webcast on Thursday, July 28, 2022, at 8:30 a.m. ET Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes o